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Accepted 16 June 2016Objective: To evaluate the implementation of the law that liberalizes voluntary abortion in Uruguay and enables
health services to offer these services to the population. Methods: The legal and regulatory provisions are de-
scribed and the national data—provided by the Ministry of Public Health’s National Information System
(SINADI)—on the number of voluntary terminations of pregnancy, the abortion method (medical or surgical),
and whether it was performed as an outpatient or inpatient are analyzed. To determine complications, the number
ofmaternal deaths and admissions to intensive care units for pregnantwomenwas used. The study period ran from
December 1, 2012, to December 31, 2014. Results: A total of 15 996 abortions were performed during the study
period; only 1.2% were surgical and 98.8% were medical. Of the latter, only 3.4% required hospitalization. Less
than half of the pregnancieswere terminated up to 9weeks of gestation and 54%were at 10 to 12weeks in a sample
from the Pereira Rossell Hospital. Conclusion: The rapid nationwide rollout of voluntary termination of pregnancy
services to all women was possible to a large degree thanks to the availability and broad acceptance of medical
abortion, facilitated by the prior experience in applying the risk and harm reduction strategy.
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Uruguay1. Introduction
Abortion was decriminalized in Uruguay in November 2012. It may
be carried out during the ﬁrst 12 weeks of pregnancy if that is the
woman’s wish [1] and during the ﬁrst 14 weeks if the pregnancy is
the outcome of an ofﬁcially reported rape.
To enable implementation of the voluntary termination of pregnancy
(VTP) law, the Ministry of Public Health drafted a decree regulating
it and published a procedures manual and technical guide for VTP in
December 2012.
One of the crucial points was deﬁning which procedure would be
preferred for pregnancy termination. In the decision-making process,
the following aspects were particularly important:
(1) Solid scientiﬁc evidence that substantiates the higher risk of
dilatation and curettage as an abortion method [2].
(2) Lack of training and resources for performing manual vacuum
aspiration (MVA) and/or electrical aspiration in Uruguay.Uruguay. Tel.: +598 27099122.
ology and Obstetrics. Published by(3) Clear scientiﬁc evidence regarding the safety and efﬁcacy
of medical termination of pregnancy up to the ninth week of
pregnancy [2,3].
(4) Experience in themedical management of abortion as part of the
risk and harm reduction strategy that has been implemented in
Uruguay in recent years. This strategy, which was started
by the nongovernmental organization Iniciativas Sanitarias in
2001, had been deployed in all of the country’s sexual and
reproductive health services, with excellent results and a well-
advanced learning curve [4–6].
(5) National experience in the medical management of incomplete
abortion following the recommendations of the International
Federation of Gynecology and Obstetrics (FIGO).
(6) It was thought that there would be a higher prevalence of
conscientious objection to voluntary termination by aspiration or
curettage. Self-administered, outpatient medical VTP was not
only a safe and effective method but was also more acceptable
for both users and health teams.
This led tomedical abortion (mifepristone andmisoprostol) becom-
ing established by the Ministry of Public Health as the procedure of
choice for performing VTP within the framework of the law. WHO’sElsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
Table 1
Total voluntary terminations of pregnancy and method used.
Study period
Method 2012–2013 2014 Total
No. (%) No. (%) No. (%)
Medical 7318 (98.3) 8483 (99.2) 15 801 (98.8)
Surgical 129 (1.7) 66 (0.8) 195 (1.2)
Total VTPs 7447 8549 15 996
Abbreviation: VTP, voluntary termination of pregnancy.
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be the health team who, after the user had followed a counseling and
guidance process and together with her, would deﬁne the time and
dose to be used.
The law that decriminalizes abortion came into force without any
major incidents in December 2012. The prior existence of sexual and
reproductive health services, the experience obtained from the risk
and harm reduction strategy, and the possibility of performing the
abortion as an outpatient procedure with medicines as an effective,
safe, and acceptable technique were key factors in the process.
The present article describes the features of the VTP process in
Uruguay, as established in Law 18.987, and the role of medical abortion
in its deployment.
2. Materials and methods
The Voluntary Termination of Pregnancy Law (Law 18.987) was
approvedby theUruguayanParliament onOctober 22, 2012, andwas reg-
ulated one month later. On the basis of these regulations, the following
procedure was established for terminating a pregnancy [7].
(1) First visit to the doctor (VTP 1), the woman indicates her deci-
sion. Compliance with the law’s requirements is conﬁrmed, an
ultrasound scan is requested to conﬁrm pregnancy and establish
the gestational age, and a blood test is performed for ABO-Rh
classiﬁcation. The patient is referred for the second visit, within
the following 24 hours.
(2) Second mandatory visit to the interdisciplinary team (VTP 2):
counseling. Three professionals (a gynecologist, a professional
from the social area, and a professional from the mental health
area) advise the patient on the options available for an unwanted
pregnancy and inform her of the reﬂection period proposed by
the law, which should not be less than 5 days consecutively.
(3) Third visit to the gynecologist (VTP 3): ﬁnal expression of the
patient’s wish. At this visit, the VTP procedure deﬁned in the
Ministry of Health’s technical guide is started.
(4) The technical guides add a fourth post-VTP follow-up visit at
which it is veriﬁed that the process is progressing satisfactorily,
contraceptive guidance is given, and the user receives the
method she has chosen.
The technical guide for VTP [8] was drafted by theMinistry of Health
to provide clinical recommendations regarding VTP procedures. It is
based on the WHO recommendations [2], with certain modiﬁcations
made to adapt it to local conditions. This guidance establishes the use
ofmedicines as themethod of choice for abortion, and preferable to sur-
gery. It stresses that the woman must be informed that the preference
for medication is based on scientiﬁc evidence, the experience acquired
at national level, and the country’s healthcare conditions. The use of
clinical recommendations should be adapted to each woman and stress
should be put on her clinical condition and the speciﬁc abortionmethod
that will be used. The treatment regime speciﬁed in this technical guide
consists of giving 200 mg mifepristone orally, followed 36–48 hours
later by 800 μg misoprostol (by the oral or vaginal route). In those
cases with a gestational age greater than 9 weeks, a second dose of
800 μg misoprostol will be given 4 hours after the ﬁrst dose. During
December 2012, only misoprostol was used because mifepristone was
not yet available in the country. From January 2013 onward, the general
rule was a combined treatment with mifepristone–misoprostol.
If the medical treatment fails or if the woman does not want to use
the drugs, a surgical procedure is performed that consists of MVA or
electrical aspiration.
After receiving guidance, the woman can use the medication
(mifepristone and misoprostol) at her home. The gynecologist will
identify those cases for which it is recommended that the procedure iscarried out at a hospital: unaccompanied women, extreme emotional
lability, limited access to health services where she lives, pregnancies
at 12 weeks, users with risk factors for VTP (multiple uterine scars,
blood dyscrasias, etc), or if the woman requests admission.
The data presented in the present article were obtained from an
observational retrospective analysis of the national data provided by
the Ministry of Public Health’s National Information System (SINADI).
The data concerning the number of VTPs and the type of procedure
were taken from the monthly compulsory report that all health
providers must submit to the Ministry of Health [9]. The study period
ran fromDecember 1, 2012, to December 31, 2014. The SINADI database
includes the total number of VTPs performed during the study period
and the abortion method chosen (medical or surgical). In the case of
medical abortions, whether the procedure was outpatient or inpatient
is also stated.
The complications report is derived from the report issued by the
National Committee for Reducing Obstetric Morbidity and Mortality,
which was created in 2011 to implement mechanisms for monitoring
maternal mortality: mandatory reporting, verbal autopsy, and
improved quality of records. Thus, the number of maternal deaths and
admissions to the intensive care unit for pregnantwomen (nearmisses)
must be reported monthly by all health providers to the Ministry of
Health. It is also mandatory to report zero maternal deaths, which
minimizes the possibility of under-recording.
As national data are limited, for example missing basic data such as
gestational age at the time of performing the VTP, it was decided that
a subanalysis from the Pereira Rossell Hospital’s Sexual and Reproduc-
tive Health Service should be included. An analysis was performed of
the number of VTPs by gestational age and the method used from
August 2014 to December 2014. The data were obtained by ﬁlling in a
pre-designed form that did not contain any identifying data.
The project was approved by the Department of Sexual and
Reproductive Health of the Ministry of Public Health, and by the
Pereira Rossell Hospital Center, School of Medicine, University of the
Republic, Uruguay.
3. Results
During the ﬁrst two years after implementation of the law, 15 996
VTPs were performed within the health system in the country as
a whole: 7447 in the period from December 1, 2012, to December
31, 2013; and 8549 in the period from January 1 to December 31,
2014 (Table 1).
In almost 99% of cases, the abortions were medical (Table 1), using
the medication schedule described in the WHO technical guidance.
Considering only the medical abortions, approximately 96% of the
women in each period used the medication as outpatients (Table 2).
Considering all procedure types, slightlymore than 3% of thewomen
had to be admitted to hospital during the VTP process (Table 2).
As regards complications, zeromaternal deaths for abortions carried
out within the framework of the VTP law were reported during the pe-
riod 2012–2013. One maternal death was reported for an illegal unsafe
abortion (in the country’s capital, Montevideo, public health sector).
Two serious complications were reported: one post-VTP hysterectomy
and one admission to the intensive care unit for an illegal unsafe
Table 2
Place of administration of voluntary termination of pregnancy medication.
Study period
Treatment location 2012–2013 2014 Total
No. (%) No. (%) No. (%)
Outpatient use 7075 (96.7) 8182 (96.5) 15 257 (96.6)
Inpatient use 243 (3.3) 301 (3.5) 544 (3.4)
Total medical VTPs 7318 (100) 8483 (100) 15 801 (100)
Abbreviation: VTP, voluntary termination of pregnancy.
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the country and no serious complications were reported.
Regarding the analysis of the data from the Pereira Rossell Hospital’s
Sexual and Reproductive Health Service, a total of 481 women received
VTP services in this hospital during the periodAugust 2014 to December
2014. In 99% of cases (476 out of 481), a medical abortion was per-
formed, applying the treatment schedules described in the Ministry’s
technical guidance. Some 46.2% were pregnancies with a gestational
age of less than 10 weeks, while 53.8% were pregnancies with a
gestational age of10 to 12 weeks and 6 days (Table 3).
4. Discussion
The results of this analysis show the broad acceptance in Uruguay of
themedical method for VTP, both by thewomen themselves and by the
health service providers. The experience acquired in the country in the
medical management of abortion, within the risk and harm reduction
model, was fundamental in deciding to use drugs as the ﬁrst choice
for the VTP.
The experience of other countries where there were legislation
changes that led to legalization of abortion reveals that it is not always
easy to put the change into practice. The examples of Zambia,
India, South Africa, and Nepal show that time, advocacy, and training
health of professionals are needed if the services are to be provided to
the women who need them. In fact, in the countries listed above,
decades have passed and there is still no universal access to legal, safe
VTP services [10,11].
In contrast, in Uruguay, these services were available nationwide
within a matter of days. The fact that it is a small country is without
doubt a facilitating factor, but it is not sufﬁcient in itself to account for
the extremely rapid deployment of VTP services. In an attempt to
analyze the factors that may be behind this startling success in imple-
mentation of the law, we would draw attention to the risk and harm
reduction strategy applied prior to the law and described in other arti-
cles in this supplement [12,13]. The political will of the executive arm
and the efﬁciency of the Ministry of Public Health’s senior ofﬁcials also
played a signiﬁcant role. However, there is no doubting that without
the availability of medical abortion, it would never have been so
successful in such a short period of time.
TheMVA techniquewith local anesthesia and no hospital admission,
which can be carried out by non-physician professionals, has been very
successful in several contexts. However, training must be given to theTable 3
Case distribution by gestational age at the time of voluntary termination of pregnancy at
the Pereira Rossell Hospital.








12 16.0 100health professionals, facilitiesmust be prepared in the different services,
equipment must be purchased, distributed, and maintained, and there
must also be a logistics system that enables them to be available at
all times in care facilities around the country. All of this requires time
and money, which is not always within countries’ possibilities. In
contrast, medical abortion has a minimum cost, which is much less
than the cost of providing care for the complications of the clandestine,
unsafe abortions that would be carried out in the absence of legal
abortion services.
The implementation ofmedical abortionwas alsomade easier by the
previous experience acquired in the use of pregnancy termination drugs
within the context of the risk and harm reduction model, which had
allowed physicians to become conﬁdent in their use.
The other feature of medical abortion that assists in the application
of the law is that it puts a certain distance between the professional
and the abortion. Prescribing some pills that the woman will take her-
self at home is a very different experience for the physician than remov-
ing the uterine contents in a surgical abortion. The distance that is
achievedwhen prescribing drugs increases the percentage of physicians
who are willing to provide these services [14].
TheMinistry of Public Health’s decision to give preference tomedical
abortion is endorsed internationally both by WHO and FIGO and there
are guidelines that also recommend it [2,3]. The WHO’s safe abortion
guidance (2012) lists manual vacuum or electric aspiration, or medical
abortion with a combination of mifepristone followed by misoprostol
as recommended methods for abortion up to 12 weeks of pregnancy.
Administration of mifepristone followed by misoprostol is safe and
effective, and does not require hospital admission of the patient, up to
9 weeks (63 days) of pregnancy. There is also limited evidence that
repeated doses of misoprostol between weeks 9 and 12 of pregnancy
are safe and effective.
In addition to the evidence and the international recommendations,
the efﬁcacy and safety of misoprostol for the termination of pregnancy
had also been evaluated at the Pereira Rossell Hospital from May 2007
to July 2009, with very favorable results [5]. During that study period,
93.3% of users did not suffer any complications after administration of
misoprostol, and those complications that were reported were mild.
No maternal deaths or admissions to the intensive care unit were
reported in this population of users. These data endorsed the safety of
misoprostol when administered at home within the framework of
professional counseling, even in a restrictive legal context.
The results observed are not different from the experience reported
in other contextswhere abortion has been decriminalized in the last de-
cade, such as Mexico City. The Mexican capital decriminalized abortion
during theﬁrst quarter of 2007, but implementing this rightwas fraught
with challenges. The most commonly used abortion method initially
was surgical abortion. In recent years, there has been a trend in reducing
the use of surgical abortion in favor of an increase in medical abortion,
initially with misoprostol and, after 2011, with the market availability
of mifepristone, with combined regimens.
By 2013, 69% of legal abortions in Mexico City were medical
abortions [15,16]. Experience in the outpatient use of medicines has
been documented for pregnancies up to a gestational age of 63 days
(9 weeks), administering 200 mg mifepristone orally followed by
800 μgmisoprostol orally, with a success rate of 97.3% [16]. For pregnan-
cies up to a gestational age of 70 days (10 weeks), the same schedule
was used, with a second dose of 800 μg misoprostol if necessary. The
success rate in these cases was 93.3% [17].
This evidence supports the outpatient use of medical abortion up
to a gestational age of 10 weeks and conﬁrms previous studies per-
formed in the USA in 2012 that showed that medical abortion was
safe and effective up to 10 weeks [18]. In fact, this treatment regimen
is already included in the US National Abortion Federation’s 2015
clinical guidelines [19].
Medical abortion is also well accepted by users. Although no speciﬁc
study has been performed on user acceptability, the reports by feminist
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tance based on themethod’s efﬁcacy, the conﬁdentiality withwhich the
process is performed (at home), and the existence of clear alternatives if
additional or emergency visits are needed during the VTP process.
The possibility of using the medication at home was highlighted as
one of ﬁve positive factors that make the VTP experience easier, accord-
ing to a study performed by the Médicos del Mundo organization in
Uruguay [20]. According to interviews of women who underwent a
VTP, “Five factors stand out for having helped women to get through
theVTP service and experience: the service’s tone, the fact that the abor-
tion can be done at home, the service’s conﬁdentiality, support from
other women going through the same experience, and care continuity.”
This is consistent with data obtained in Mexico City [17], where
76.6% of the women included in the study viewed the medical abortion
process as easy or very easy and 77.8% would choose it again if they had
to undergo another VTP.
This experience in Uruguay may be useful for other countries that
have already liberalized their abortion laws, but have not yet managed
to put them into practice and also for countries that are currently in
the process of liberalizing the laws. We believe that a medical model
for legal termination of pregnancy, such as that implemented in
Uruguay, substantially increases the possibility of deploying these ser-
vices throughout the national health system, with a minimum cost
that is quickly recovered by reducing the complications of clandestine
abortion, administered with a low-cost, quick provider training pro-
gram. In countries with fewer physicians per inhabitant than Uruguay,
other health professionals can be trained to provide these services, as
recommended by WHO. All these considerations, taken together, have
encouraged us to share this experience through this publication.
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